OVERVIEW

Cancer Summaries and Commentaries™: Report from Orlando on Advances in the Treatment of Graft-versus-Host Disease (GVHD) is organized by Physicians' Education Resource, LLC (PER).

Release Date: December 24, 2019
Expiration Date: December 24, 2020

Accreditation:
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Activity Overview:
Cancer Summaries and Commentaries™: Report From Orlando on Advances in the Treatment of GVHD is an online activity developed to update healthcare providers on data presented at the 2019 American Society of Hematology Annual Meeting, held in December in Orlando, Florida. This activity reviews 9 abstracts with some of the most interesting and clinically relevant data on graft-versus-host disease (GVHD) presented at the meeting. Short summaries of key clinical data for selected abstracts is accompanied by commentary from experts in the field and provide insight regarding the importance of the studies and the possible impact of their findings on clinical practice.

Learning Objectives:
Upon successful completion of this educational activity, you should be better prepared to:
• Outline graft-versus-host disease (GVHD) biology, pathogenesis, and risk factors to better manage GVHD
• Explain findings from recently conducted trials that assessed emerging strategies for the treatment and management of GVHD
• Consider recent clinical trial data in the context of evolving treatment paradigms in the management of patients with GVHD

Benefits of Participating:
• Learn about new strategies targeting the biology of graft-versus-host disease (GVHD)
• Hear about novel biomarker algorithms to predict survival in patients with GVHD
• Learn about current and new treatment strategies for GVHD
• Explore emerging targets to the prevention of GVHD
• Be informed about recent clinical trials data and earn CME credit